ucsf logo

Matthew Bucknor, MD

Diagnostic Radiology
Portrait of Matthew Bucknor
Portrait of Matthew Bucknor
ucsf logo

Matthew Bucknor, MD

Diagnostic Radiology

On this page

About me

Dr. Matthew Bucknor is a radiologist who diagnoses and treats diseases and injuries of the musculoskeletal system. Guided by imaging technologies including X-ray, ultrasound, CT and MRI, he performs procedures such as injections, tissue sampling and focal tumor treatments (a noninvasive technique for treating small tumors using energy sources).

Bucknor's research focuses on developing magnetic resonance–guided focused ultrasound, a noninvasive method for treating tumors using sound waves. He oversees UCSF clinical trials that evaluate ways to use this technology for various conditions.

Bucknor earned his medical degree from Stanford University School of Medicine. He completed a residency in radiology at UCSF and a fellowship in musculoskeletal imaging and intervention at Stanford.

Honoring his commitment to promoting diversity, inclusion and health equity in medicine, UCSF named Bucknor a John A. Watson Faculty Scholar and awarded him the Chancellor Award for Dr. Martin Luther King Jr. Leadership.

Education & training

Board certification

  • Diagnostic Radiology, American Board of Radiology

Fellowship

  • Musculoskeletal Radiology, Stanford University School of Medicine

Residency

  • Radiology, General, University of CA at San Francisco School of Med

Internship

  • Internal Medicine, Kaiser Foundation Hospital - San Francisco

Degree

  • MD, Stanford University

My expertise

My research

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.